Lifespan Edge, the next-generation longevity clinic co-founded by futurist John Mauldin and preventive medicine pioneer Dr. Michael Roizen, has announced the opening of two new locations in West Palm Beach, Florida, and Columbia, Maryland. A third premier destination is planned for Scottsdale, Arizona. This expansion marks a significant milestone in the company's mission to make personalized, evidence-based longevity care more accessible.
Founded in 2024, Lifespan Edge was created to bridge cutting-edge longevity research with individualized clinical care for individuals seeking to optimize healthspan, cognitive vitality, and quality of life. Dr. Michael Roizen, Chair of the Board and Co-Founder, emphasized that healthcare should begin decades before disease appears, focusing on modifiable factors that influence aging. Through personalized care, informed lifestyle choices, and emerging scientific advances, Lifespan Edge aims to empower individuals to take greater control of their long-term health.
The new locations include 2528 Okeechobee Blvd. in West Palm Beach, Florida, and 10700 Charter Drive, Suite 200 in Columbia, Maryland, with a premier luxury wellness destination coming soon in Scottsdale, Arizona. Each location offers a concierge-style experience combining advanced diagnostics, physician-guided evaluations, and personalized strategies focused on prevention, performance, and healthy aging.
Interest in longevity medicine has accelerated as consumers increasingly seek proactive approaches to maintaining cognitive function, metabolic health, physical resilience, and overall vitality. Rather than treating disease after symptoms arise, Lifespan Edge emphasizes early identification of risk factors and creation of individualized plans that support long-term wellness. John Mauldin, President and Co-Founder, stated that the company was founded to bring together leading physicians, science-driven medicine, and personalized care, translating longevity research into practical strategies for healthier lives.
Among the areas attracting scientific interest is Therapeutic Plasma Exchange (TPE), a medical procedure with established clinical uses that is being investigated for potential applications related to aging and neurodegenerative disease. Notable research includes the AMBAR (Alzheimer Management by Albumin Replacement) clinical trial, which evaluated plasma exchange with albumin replacement in patients with mild-to-moderate Alzheimer’s disease. Published findings reported promise in slowing decline in certain cognitive and functional measures, though investigators emphasized the need for additional research.
Dr. Roizen has long advocated that biological age and chronological age are not always the same, emphasizing that lifestyle choices—including nutrition, physical activity, stress management, purpose, and social connection—can meaningfully influence long-term health. He believes prevention should remain the foundation of modern medicine, noting that people have more influence over their future health than they often realize.
With additional locations planned and a continued focus on personalized medicine, Lifespan Edge aims to redefine what aging can look like in the decades ahead. The expansion comes amid growing national recognition for its leadership team; Dr. Roizen was recently featured in Entrepreneur and TopDoctor Magazine, where he discussed his vision for longevity science and the importance of empowering individuals to take an active role in their long-term health.
